U.S.-based robotics firm 1X has started full-scale production of its humanoid robot NEO at a new manufacturing facility in Hayward, California.
The factory marks a key step toward commercializing general-purpose humanoid robots designed for home use. The company says the robots are built to safely operate alongside humans and assist with everyday tasks such as mobility support, light household activity, and routine interaction.
Spanning 58,000 square feet, the facility currently employs more than 200 workers and is expected to expand further as production scales. It has the capacity to produce up to 10,000 robots annually, with plans to increase output beyond 100,000 units by 2027. The setup is designed for rapid iteration as hardware and AI systems evolve.
The company has already seen strong early demand. It said its first-year production capacity of over 10,000 units sold out within five days of launch in October, signaling early commercial interest in humanoid home robotics.
Full-stack manufacturing push
A key feature of the factory is its vertically integrated production model. 1X designs and manufactures core components in-house, including motors, batteries, sensors, structures, and transmission systems.
This approach allows the company to control the entire production process, from raw material handling to final assembly. It also reduces reliance on external suppliers and supports faster iteration cycles, especially for hardware upgrades and safety improvements.
“We’re building the world’s safest, most reliable humanoid robots—right here in Hayward, California,” said Vikram Kothari, VP of Manufacturing & Hardware.
The company says its setup includes automated motor manufacturing lines and systems that handle precision tasks such as copper coil winding. This level of integration is aimed at improving reliability, reducing production bottlenecks, and scaling manufacturing efficiently without outsourcing key subsystems.
Robots produced at the facility are currently being routed to internal testing, validation, and research environments. Customer shipments are expected to begin in 2026, starting with early access users before wider rollout.